Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Cell Chemical Biology|October 3, 2017
Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent InhibitorsSherry Niessen, Melissa M Dix, Sabrina Barbas, et al.Journal of Thrombosis and Haemostasis : JTH|February 15, 2021
Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase responseLiam Townsend, Helen Fogarty, Adam Dyer, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 30, 2020
Telehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemicMairead O'Donovan, Catherine Buckley, Julie Benson, et al.Blood Advances|July 1, 2025
Effect of age on ISTH-BAT scores and Low VWF diagnosis in the Zimmerman ProgramFerdows Atiq, Pamela A Christopherson, Dearbhla Doherty, et al.Blood|September 17, 2017
Novel insights into the clinical phenotype and pathophysiology underlying low VWF levelsMichelle Lavin, Sonia Aguila, Sonja Schneppenheim, et al.Blood|February 17, 2019
Increased galactose expression and enhanced clearance in patients with low von Willebrand factorSonia Aguila, Michelle Lavin, Niall Dalton, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 29, 2025
Spinal Stenosis: An Emerging Complication of Ageing in People With HaemophiliaClaire Kelly, Mark McGowan, Niamh Larkin, et al.Journal of Medicinal Chemistry|August 29, 2012
Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancerJ Jean Cui, Michele McTigue, Mitchell Nambu, et al.Journal of Medicinal Chemistry|August 5, 2011
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)J Jean Cui, Michelle Tran-Dubé, Hong Shen, et al.Journal of Medicinal Chemistry|October 15, 2020
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19Robert L Hoffman, Robert S Kania, Mary A Brothers, et al.Pageof 11